Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rational Emotive Behavior Therapy01:24

Rational Emotive Behavior Therapy

608
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
608
Drug Therapy01:28

Drug Therapy

376
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
376
Cognitive Therapy01:25

Cognitive Therapy

1.4K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.4K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

653
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
653
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

879
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
879
Modeling in Therapy01:26

Modeling in Therapy

668
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
668

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Cognitive Behavioral Therapy for Worry Versus Befriending Therapy in Individuals with Persecutory Delusions: A Randomized Trial.

Schizophrenia bulletin open·2026
Same author

Longitudinal associations between volatility priors and delusions in individuals recovering from an acute psychotic episode.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026
Same author

Trauma-Informed Principles on Informing Caregivers of Referrals to Child Protective Services.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
Same author

Characterizing artificial intelligence (AI) psychosis in a large academic medical setting: evidence of the new clinical phenomenon and the vulnerability of those in early phases of psychosis.

medRxiv : the preprint server for health sciences·2026
Same author

Use of Cardiopulmonary Bypass for Complex Robotic Left Upper Lobectomy After Prior Mantle Irradiation.

Annals of thoracic surgery short reports·2026
Same author

Longitudinal relationships among dissociation, paranoia, and anxiety in a clinical sample of individuals with schizophrenia-spectrum conditions.

Psychiatry research·2026

Related Experiment Video

Updated: Mar 18, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

628

Integrating Recovery-Oriented Cognitive Therapy Into Medication Management Visits: Feasibility and Acceptability.

Aaron P Brinen1, Ali Sloan2, Lauren M Hall3

  • 1Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville.

Psychiatric Services (Washington, D.C.)
|March 17, 2026
PubMed
Summary

Integrating recovery-oriented cognitive therapy (CT-R) into medication checks for schizophrenia improved symptoms and social functioning. The IMPACT program demonstrated feasibility and acceptability in this patient group.

Keywords:
Cognitive-Behavioral Therapy (CBT)MedicationsPsychosisPsychotherapySchizophrenia

More Related Videos

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

725
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

628
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

725
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Mental Health Treatment

Background:

  • Psychotherapy integration into medication management has declined.
  • Recovery-oriented cognitive therapy (CT-R) offers significant benefits.

Purpose of the Study:

  • To evaluate the feasibility and acceptability of integrating CT-R into psychiatric medication management.
  • To assess the IMPACT program for individuals with schizophrenia spectrum disorders.

Main Methods:

  • The IMPACT program integrated CT-R elements into medication visits.
  • 22 participants with schizophrenia spectrum disorders completed the 12-month study.
  • Psychiatrists delivered CT-R elements in 74% of sessions.

Main Results:

  • All participants completed the 12-month treatment.
  • Significant improvements observed in overall symptoms (Cohen's d=0.83) and social functioning (Cohen's d=0.88).
  • Moderate improvement in beliefs about recovery.

Conclusions:

  • The IMPACT program is a feasible and acceptable treatment for schizophrenia spectrum disorders.
  • Preliminary evidence supports the integration of CT-R into medication management.
  • A randomized controlled trial of the IMPACT program is warranted.